iBio, Inc. Common Stock

IBIONASDAQUSD
1.67 USD
0.08 (5.03%)AT CLOSE (11:59 AM EDT)
1.66
0.01 (0.72%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.66
0.01 (0.72%)
🔴Market: CLOSED

IBIO is currently priced at $1.67. Technical and fundamental signals converge bearishtechnicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bearish long-term moving average alignment. Valuation metrics place IBIO at a fair price relative to peers.

Technical & fundamental data as of Jun 26, 2026.

Open?$1.60
High?$1.68
Low?$1.57
Prev. Close?$1.59
Volume?1.5M
Avg. Volume?820.2K
VWAP?$1.62
Rel. Volume?1.84x
Bid / Ask
Bid?$1.36 × 100
Ask?$1.91 × 100
Spread?$0.55
Midpoint?$1.64
Valuation & Ratios
Market Cap?83.0M
Shares Out?49.7M
Float?31.5M
Float %?91.3%
P/E Ratio?N/A
P/B Ratio?1.07
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Employees
20
Market Cap
79.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2008-08-19
Address
600 MADISON AVENUE, SUITE 1601
NEW YORK, NY 10022-1737
Phone: 302 355-0650
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
5
Momentum?
65
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?0.46Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.91%High
Short Interest?3.8M
Days to Cover?4.8
Free Float31.5M
Avg Daily Volume780.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?11.88Strong
Quick Ratio?11.88Strong
Cash Ratio?7.32Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
1.07CHEAP
P/S?
Peers
100
S&P
3
276.54HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.8CHEAP
EV/Sales?
Peers
100
S&P
3
117.77HIGH
Returns & Efficiency
ROE?
S&P
7
-24.1%WEAK
ROA?
S&P
3
-21.7%WEAK
Cash Flow & Enterprise
FCF?$-22181000
Enterprise Value?$35.3M
Fundamentals ratios updated end of day